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Invasive fungal infections, specifically candidemia, constitute major public health
problems with high mortality rates. Therefore, in the last few years, the
development of novel diagnostic methods has been considered a critical issue.
Herein we describe a multiplex PCR strategy allowing the identification of 8
clinically relevant yeasts of the Candida genus, namely C. albicans, C. glabrata,
C. parapsilosis, C. tropicalis, C. krusei, C. guilliermondii, C. lusitaniae and
C. dubliniensis. This method is based on the amplification of two fragments from
the ITS1 and ITS2 regions by the combination of 2 yeast-specific and 8 species-
specific primers in a single PCR reaction. Results from the identification of 231
clinical isolates are presented pointing to the high specificity of this procedure.
Furthermore, several Candida isolates were identified directly from clinical
specimens which also attests to the method’s direct laboratory application. The
results from the multiplex reactions with other microorganisms that usually co-
infect patients also confirmed its high specificity in the identification of Candida
species. Moreover, this method is simple and presents a sensitivity of approximately
2 cells per ml within 5 hours. Furthermore, it allows discrimination of individual
Candida species within polyfungal samples. This novel method may therefore
provide a clinical diagnostic procedure with direct applicability.
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Introduction
Invasive fungal infections represent a public health
problem of major importance [1,2]. In particular,
candidemia has been reported within similar rates in
different countries, ranging from 0.200.38 per 1,000
admissions and from 3.04.4 per 100,000 patient days
[3]. This emergence is often associated with human
immunodeficiency virus (HIV) or advancedmedical and
surgical interventions that compromise patient immu-
nity, e.g., bone-marrow or solid-organ transplants,
aggressive chemotherapy and broad application of
antifungal agents [2]. In fact, nosocomial fungal blood-
stream infections are an increasingly significant cause of
morbidity, with an estimated mortality of 2538% [4].
Candida albicans is the most common and clinically
relevant pathogen of the genus. However, there has been
a significant trend towards the emergence of species
other than C. albicans, with a particular increase in
C. glabrata frequency [3,5,6] and to a lesser extent,
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C. parapsilosis and C. tropicalis [7]. In addition, given
that several non-C. albicans Candida species are intrin-
sically resistant to common antifungal agents, accurate
identification methods are critical for the establishment
of appropriate antifungal therapy [7].
The cornerstone of laboratory detection of blood-
stream fungal infections, including candidemia, re-
mains direct examination and conventional blood
culture. However, these methods are of limited clinical
value since there are negative outcomes in as high as
50% autopsy-confirmed cases of candidemia. In addi-
tion, cultures may only become positive late in the
infection [8]. Furthermore, most phenotypic methods
of identification used in clinical laboratories are often
time-consuming and may lead to inconclusive results.
For example, phenotypic tests such as VITEK and
ID32C systems require several days before biochemical
reactions can be interpreted [9]. On the other hand,
molecular approaches have the potential to detect
candidemia with increased sensitivity and specificity.
Buchman et al. were the first to demonstrate that
detection of C. albicans in clinical specimens was
possible by PCR amplification of the lanosterol-
alpha-demethylase (L1A1) gene [10]. Other PCR-based
techniques have been developed using amplification of
target DNA, providing alternative strategies for the
diagnosis and identification of fungal pathogens [11
14]. Fungal ribosomal genes are common DNA targets
in PCR-based procedures for the identification of fungi
at the species level. The highly variable sequences of
internal transcribed spacer regions ITS1 and ITS2
flanked by the relatively conserved coding regions of
18S, 5.8S and 28S nuclear rRNA genes have been used
in various PCR-based formats for the identification of
medically important yeasts [13,1517]. Even though
these molecular techniques are highly sensitive and
specific, their limited applicability has been the need for
expensive equipment not readily accessible to many
diagnostic laboratories.
We describe a rapid and simple multiplex PCR-based
method able to specifically identify 8 clinically relevant
Candida species (C. albicans, C. glabrata, C. parapsi-
losis, C. tropicalis, C. krusei, C. guilliermondii,
C. lusitaniae and C. dubliniensis) based on the ampli-
fication of particular DNA fragments of the ITS1 and
ITS2 regions. The method combines two yeast-specific
primers and eight Candida species-specific primers in a
single PCR reaction yielding two amplicons of different
sizes for each species. In addition, this method provides
the following advantages over currently available tech-
niques: (1) it can be used to test several clinical samples,
including blood culture bottles and urine samples, (2)
whole yeast cells may be employed directly in the PCR
mixture, (3) it is highly specific and sensitive, with a
detection limit of 2.1590.25 cells/ml, (4) it has the
potential to discriminate individual Candida species in
polyfungal infections to a maximum ratio of 1:10, and
(5) it presents good reproducibility among different
PCR thermal cyclers and within different laboratories.
Altogether, the features of this method point to a novel
and highly advantageous application in the identifica-
tion of Candida species in both clinical diagnosis and
epidemiological studies.
Materials and methods
Yeast and bacterial strains
A total of 231 yeast isolates (90 Candida albicans, 61
C. parapsilosis, 25 C. tropicalis, 19 C. krusei, 18
C. glabrata, 13 C. guilliermondii and 5 C. lusitaniae)
were recovered from clinical specimens in two Portu-
guese medical institutions, one in the northern region
(Hospital de São João, Porto) and the other in
the southern area of the country (Hospital de Santa
Maria, Lisboa). The following type Candida strains;
C. albicans ATCC 18804, C. glabrata ATCC 2001,
C. tropicalis ATCC 750, C. parapsilosis ATCC 22019,
C. krusei ATCC 6258, C. lusitaniae ATCC 34449,
C. guilliermondii ATCC 6260 and C. dubliniensis
ATCC MYA-646 were used in the present studies.
The identification of yeast isolates was carried out by
conventional biochemical techniques in both medical
institutions using the VITEK (bioMérieux Vitek, Inc.,
MO, USA) or ID32C (bioMérieux Vitek) yeast identi-
fication systems. The isolates were stored on yeast
extract peptone dextrose (YEPD) agar plates. In
addition, Aspergillus fumigatus MUM 98.02, A. niger
MUM 03.01, A. flavus MUM 00.29, A. terreus MUM
94.09, A. nidulans MUM 98.32, Cryptococcus neofor-
mans var. neoformans ATCC 28957,Saccharomyces
cerevisiae Y10000, as well as Mycobacterium tubercu-
losis H37Rv, M. avium 3509, Escherichia coli HB101,
Staphylococcus aureus 0400, Pseudomonas aeruginosa
ATCC 27853 and Bacillus subtilis ATCC 6051 were
used for PCR cross-reactivity testing.
Furthermore, 27 BACTEC blood culture bottles
(Becton Dickinson Microbiology Systems, MD, USA)
which were identified as positive for bacteria and/or
yeasts through the use of a blood culture instrument
and Gram staining and 19 urine samples found to be
positive for yeasts and/or bacteria were also directly
analysed by PCR. Identification was simultaneously
carried out using the VITEK yeast biochemical card.
Twenty blood culture bottles and 14 urine samples
were noted to contain yeasts, while negative controls
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included blood culture bottles and urine samples
positive for different bacterial species. While no DNA
isolation procedure was required for urine samples,
Candida DNA was isolated from aliquots of blood
culture bottles, in order to eliminate the presence of
PCR inhibitory factors (see below).
Primer design
Yeast-specific universal primers UNI1 (5?-GTCAAAC
TTGGTCATTTA-3?) and UNI2 (5?-TTCTTTTCCTC
CGCTTATTGA-3?) were used to amplify the internal
transcribed spacer regions 1 (ITS1) and 2 (ITS2),
including the 5.8S rRNA of the most relevant yeast
pathogens associated with human disease [18]. In
addition, the species-specific primers Calb, Cgla,
Ckru, Cpar, Ctro, Clus, Cgui and Cdub were designed
based on the sequence data for the ITS1 and ITS2
regions of the reference strains and of all clinical
isolates from the Candida genus available in the
EMBL/GenBank databases. The sequences were com-
pared using the DNAMAN for Windows software
(Lynnon Corporation, Quebec, Canada) in order to
design primers to specifically amplify DNA from
C. albicans, C. glabrata, C. krusei, C. parapsilosis,
C. tropicalis, C. lusitaniae, C. guilliermondii and
C. dubliniensis, respectively (Table 1). In the multiplex
PCR, the species-specific primers form a pair with the
universal primer UNI2, with the exception of Clus,
which pairs with UNI1 (Fig. 1).
DNA isolation
For DNA extraction of yeasts in culture, cells were
grown overnight in YEPD medium at 268C with
aeration on a mechanical shaker (150 rpm) [19].
Cells were harvested by centrifugation and the pellet
suspended in 200 ml of lysis buffer (2% Triton X-100,
1% SDS, 100 mM NaCl, 10 mM Tris-HCl, and 1 mM
EDTA, pH 8.0). For cell disruption, 200 ml of 0.5 mm-
diameter glass beads and 200 ml of phenol/chloroform
(1:1) were added and the tubes were shaken for three
60-second intervals interspersed with periods of cooling
on ice. After disrupted cell debris was removed by a 5
min centrifugation at 3,000 g, the supernatant was
collected and 1 ml of cold isopropanol was added
before mixing by inversion. The tubes were centrifuged
for 3 min at 3,000 g and the sediment suspended in
400 ml of TE buffer (100 mM Tris-HCl, 1 mM EDTA,
pH 8.0). A 5-min treatment with RNase A (1 mg/ml) at
378C was then carried out before adding 10 ml of 3 M
sodium acetate. DNA was further precipitated by
addition of 1 ml of isopropanol, mixing by inversion
and further centrifugation. Finally, the sediment was
air-dried and the DNA suspended in 50 ml of ultra-
filtered water. DNA content and purity were deter-
mined by spectral photometry at 260 and 280 nm and
diluted to a 100 ng/ml final concentration. The DNA
isolation from whole blood and blood culture bottles
was adapted from elsewhere [20] with minor alterations.
Four hundred ml of 10TXTE buffer (10 mM Tris-
HCl, 1mM EDTA, 1% Triton X-100, pH 8.0) were
added to 3.6 ml of blood sample and the mixture
incubated for 20 min at room temperature to lyse blood
cells. Yeast cells were collected by centrifugation at
3,000 g for 10 min and washed with 1TXTE buffer
and with 20 mM Tris-HCl (pH 8.3). The erythrocyte-
free pellet was then resuspended in 180 ml of ATL lysis
buffer and 20 ml of proteinase K (1.7 mg/ml). The
mixture was incubated at 658C for 1 h, 200 ml of AL
buffer were added and the sample was heated at 708C
for 10 min. After these steps, 200 ml of ethanol were
added to each sample and the mixtures were applied to
Table 1 Universal and species-specific primers used in Candida species amplification and size of fragments visualized under agarose gel
electrophoresis







Trost et al., 2004
[18]
C. albicans Calb AGCTGCCGCCAGAGGTCTAA 583/446
C. glabrata Cgla TTGTCTGAGCTCGGAGAGAG 929/839
C. krusei Ckru CTGGCCGAGCGAACTAGACT 590/169
C. tropicalis Ctro GATTTGCTTAATTGCCCCAC 583/507
C. parapsilosis Cpar GTCAACCGATTATTTAATAG 570/370
C. guilliermondii Cgui TTGGCCTAGAGATAGGTTGG 668/512
C. lusitaniae Clus TTCGGAGCAACGCCTAACCG 433/329
C. dubliniensis Cdub CTCAAACCCCTAGGGTTTGG 591/217
*Amplicon sizes result from multiplex PCR amplification using yeast-specific primers (UNI1 and UNI2) and corresponding species-specific
primer.
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QIAamp mini spin columns with 2 ml collection tubes,
centrifuged at 5,000 g for 1 min and washed twice with
500 ml of AW buffer. The columns were then washed
twice with 50 mM EDTA and twice with AW buffer in
order to chelate PCR inhibitory factors. DNA was
eluted with 100 ml of previously heated AL buffer and
kept at 208C until PCR. ATL lysis buffer, AL buffer,
AW buffer, proteinase K and the spin columns were
purchased from Qiagen, Hilden, Germany.
PCR amplification
Multiplex PCR amplification was performed in a 20 ml
volume consisting of 0.8PCR buffer [160 mM
(NH4)2SO4, 670 mM Tris-HCl (pH 8.8)], 3.5 mM
MgCl2, dNTP mixture (200 mM each), primer mixture
(UNI1 and UNI2, 0.55 mM each; Cgui, 0.05 mM; Calb
and Ckru, 0.15 mM each; Cgla, Ctro and Clus, 0.2 mM
each; Cpar, 0.3 mM; Cdub, 0.4 mM), 1 U Taq DNA
polymerase and 50 ng genomic DNA template, with the
remaining volume consisting of sterilized water. The
amount of template DNA used was quantified by
spectrophotometry. A 2 ml volume was used when the
template was urine or isolated Candida DNA, either
from whole blood samples or aliquots from blood
culture bottles. For colony-PCR, part of a single colony
was suspended directly in the PCR mixture with a
sterile toothpick. PCR was routinely carried out in a
Biometra Tpersonal (Whatman Biometra, Goettingen,
Germany) thermal cycler under the following cycling
conditions: 40 cycles of 15 s at 948C, 30 s at 558C, and
45 s at 658C, after a 10-min initial period of DNA
denaturation and enzyme activation at 948C. Addition-
ally, multiplex PCR reactions were performed in four
different thermal cyclers: iCycler and MyCycler (Bio-
Rad, CA, USA), Primus 96 (MWG Biotech AG,
Ebersberg, Germany) and GeneAmp PCR System
9600 (Perkin-Elmer, MA, USA) in order to confirm
PCR reaction reproducibility. Negative control reac-
tions were performed simultaneously with each test run
by replacing the template DNA with sterilized water in
the PCR mixture. Ten ml aliquots of each amplification
product were separated by electrophoresis in a 2%
agarose gel. Ethidium bromide staining (0.5 mg/ml)
allowed the visualization of DNA fragments with a
digital imaging system (Alpha Innotech Corporation,
CA, USA) and species identification was possible by
comparison with a 100-bp DNA ladder (Fermentas
International Inc., Ontario, Canada). Mycobacterium
avium subsp. paratuberculosis strain k10, Mycobacter-
ium tuberculosis CDC1551, and Nocardia farcinica
IFM10152 were tested using in silico PCR (http://
www.in-silico.com/multiplex_PCR/).
Detection limit of Candida yeasts in whole blood
In order to determine the detection limit of Candida
cells in whole blood by multiplex PCR, fresh human
blood obtained from healthy volunteers was seeded
with cells from each Candida species to a concentration
of 5102 CFU/ml. Yeast-cell number was estimated by
haemocytometer counting and confirmed by plating
serial dilutions of seeded blood onto Sabouraud agar
plates and colony counting after 2 days of incubation at
308C. The seeded blood was then serially diluted with
whole blood to obtain yeast concentrations ranging
from 2.5102 to 1.25 cells/ml and 3.6 ml of the diluted
samples were used for isolation of Candida DNA.
Multiplex PCR amplification was then carried out
using 2 ml of isolated DNA as template (see above).
Flow cytometry analysis
In order to eliminate the interference of DNA from
dead cells, cell viability was determined for quantifica-
tion of DNA in samples. Plasma membrane integrity
was determined by examining cellular permeability to
propidium iodide (Sigma-Aldrich Corporation, MO,
USA) as described elsewhere [21]. Fluorescence analy-
sis was carried out by flow cytometry with an EPICS
XL-MCL (Beckman-Coulter Inc., CA, USA) flow
cytometer, equipped with an argon-ion laser emitting
a 488 nm beam at 15 mW.
Results
Sequence analysis and multiplex PCR strategy
Previously designed fungus-specific universal primers
UNI1 and UNI2 were used to amplify the internal
transcribed spacer regions 1 and 2, including the 5.8S
rRNA region [18]. As shown in Fig. 1 and reported by
Trost and colleagues, predicted PCR products obtained
by amplification using these universal primers were
found to vary among Candida species, ranging
in length from 433 bp (C. lusitaniae) to 929 bp
(C. glabrata) [18]. In addition, DNA from clinically
Fig. 1 Multiplex PCR strategy. Organization of fungal
ribosomal genes with universal and species-specific
primer targets indicated. Arrows indicate the direction
of PCR amplification.
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relevant yeasts other than Candida, including species
from the genus Cryptococcus, Saccharomyces and
Trichosporon would also be amplified into a single
PCR fragment using the universal primers [18]. For
most Candida species, the sizes of the obtained frag-
ments are not sufficient to promote direct identifica-
tion. Thus, species-specific variations within ITS1 and
ITS2 sequences were used to design primers for
amplification of an internal fragment with a lower
length (Fig. 1), that could allow direct identification by
only a PCR reaction avoiding the restriction analysis
described by Trost and collaborators [18]. ITS1 and
ITS2 sequences from the reference strains and from all
clinical Candida isolates displayed in EMBL/GenBank
database were analysed by intraspecies alignments
using DNAMAN for Windows software (Lynnon
Corporation, Quebec, Canada) to find blocks of
conserved regions among the different strains. These
sequences were compared inter-species in order to find
variable regions that allowed the design of specific
primers to each species. Interferences from both
C. orthopsilosis and C. metapsilosis in C. parapsilosis
identification and from C. famata and other species
of the C. guilliermondii clade (C. fermentati and
C. carpophila) in C. guilliermondii identification
[22,23] were ruled out by sequence analysis and multi-
plex PCR. This in silico study was concluded with the
design of primers in variable regions among species but
at the same time conserved between strains (Table 1),
thus excluding possible intraspecies variability.
Multiplex PCR amplification
In order to develop a protocol that could allow the
specific identification of each Candida species studied
in a single reaction, a simple step-by-step protocol of
multiplex PCR optimization was developed [24]. The
results of multiplex PCRusing isolated DNA from each
species allowed the identification of up to eight
clinically relevant yeasts in a single PCR reaction by
the use of eight species-specific primers together with
the previously described universal primers [18]. Multi-
plex PCR directly from living/intact yeast whole cells
(commonly referred as colony-PCR [25]) was also
assessed. PCR conditions were maintained and the
DNA was replaced by whole yeast cells, where the
initial 10 min at 948C in the PCR protocol was
sufficient to disrupt cell integrity allowing DNA
release. Multiplex PCR reactions performed with yeast
cells yielded both universal and species-specific ampli-
cons (Fig. 2B).
Identification of clinical yeast isolates
To validate the methodology described, a wide scan of
231 clinical isolates, previously characterized by con-
ventional phenotypic systems, was carried out using the
multiplex PCR-based approach. Comparison of the
results of the two identification approaches (Table 2)
showed discrepancies in species identification for 18
isolates representing 7.8% of the total. The multiplex
PCR identification of the discrepant isolates was
further confirmed using PCR fingerprinting (Fig. 2E)
[26], which demonstrated the accuracy of the multiplex
PCR identifications. No isolates of C. dubliniensis were
found in the clinical specimens provided by the health
care institutions. For this reason, results for C. dubli-
niensis are not included in the agarose gel presented in
Fig. 2B. The most frequent misidentifications of the
VITEK/ID32C analysis were of C. parapsilosis (7/18 of
all discrepant identifications), followed by C. albicans
(5/18), C. tropicalis (4/18), C. krusei (1/18) and
C. guilliermondii (1/18). In addition, the most common
misidentification was C. tropicalis for C. parapsilosis.
Taking into account the misidentification percentage
for each species regarding the number of isolates
wrongly identified by the VITEK or ID32C systems,
C. tropicalis was the most often misidentified species
(16% of the C. tropicalis isolates), followed by
C. parapsilosis (11.5%), C. guilliermondii (7.7%),
C. albicans (5.6%) and C. krusei (5.3%).
Identification of Candida species in polymicrobial mixtures
Theoretically, the strategy here described would be able
to simultaneously identify in a single multiplex PCR
reaction coexisting yeast species in mixed samples. In
order to experimentally assess this hypothesis, samples
with two or three mixed Candida species were tested.
The results showed that the multiplex method discri-
minates the different species present in polyfungal
samples (Fig. 2C) by the amplification of the fragments
corresponding to each Candida species present. In fact,
multiple species can be identified to a maximum cell
ratio of 1:10, where for lower ratios the less abundant
yeast species could not be detected (data not shown). In
addition, in the case of polymicrobial samples (mixed
fungal and bacterial cells) no detectable PCR products
were obtained using as template Escherichia coli,
Staphylococcus aureus, Pseudomonas aeruginosa and
Bacillus subtilis bacterial DNA, although Candida
species could be identified without interference (data
not shown). This confirms the specificity of the
proposed methodology. In addition, common
microorganisms which usually cause infection in im-
munocompromised populations with candidemia, such
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as Mycobacterium tuberculosis, M. avium and Nocardia
farcinica did not present cross-reactivity with Candida
species (data not shown).
Identification of yeasts directly from urine and blood culture
bottles
In order to directly apply this methodology to clinical
samples, direct detection and identification of yeast
cells in blood culture bottles (n27) and urine samples
(n19) was assessed. To avoid cellular growth, the
PCR reactions were performed in the samples from
blood culture bottles immediately after detection of
growth and in the case of urine samples, frozen aliquots
were tested after positive indicators of development
was obtained. The results for the Candida species
present in the analysed samples were in accordance
with the presumptive identification provided by the
health care institutions that carried out simultaneous
phenotypic identification (Table 3). No cross-reactivity
was detected in control samples positive for bacteria
(7 samples) and at the same time, no interference in
the identification of Candida species was observed
in polymicrobial samples (2 samples constituted C.
albicans with either S. aureus or P. aeruginosa).
A step forward in the application of the multiplex
PCR described would be the detection of cases of
candidemia directly from blood samples. In this sense
Fig. 2 Agarose gel showing the results obtained for multiplex PCR of isolated yeast genomic DNA (A) or yeast whole cells (B) as template.
Lanes: L, 100-bp DNA ladder; 1, C. albicans; 2, C. glabrata; 3, C. krusei; 4, C. tropicalis; 5, C. parapsilosis; 6, C. guilliermondii, 7, C. lusitaniae;
and 8, C. dubliniensis. (C) Multiplex PCRof Candidamixtures in 1:1 ratios. Lanes: L  100-bp DNA ladder; M1-C. albicansC. glabrata, M2-C.
albicansC. krusei, M3-C. albicansC. tropicalis, M4-C. albicansC. parapsilosis and M5-C. albicansC. glabrataC. krusei. (D) Sensitivity
of multiplex PCR. DNAwas isolated from whole blood with different levels of artificial infection with Candida albicans. Lanes: L, 100-bp DNA
ladder; B1, 2.5102; B2, 2.5101; B3, 5; B4, 2.5; and B5, 1.25 cells/ml. (E) PCR fingerprinting using primer T3B of the Candida isolates with
different identification using multiplex PCR and VITEK/ID32C. Lanes: L, 100-bp DNA ladder; 1, C. albicans type strain; 26, C. albicans (as
identified by multiplex PCR); 7, C. parapsilosis type strain; 814, C. parapsilosis (as identified by multiplex PCR); 15, C. tropicalis type strain; 16
19, C. tropicalis (as identified by multiplex PCR); 20, C. krusei type strain; 21, C. krusei (as identified by multiplex PCR); 22, C. guilliermondii
type strain; and 23, C. guilliermondii (as identified by multiplex PCR).
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and to further characterize the sensibility of the
methodology, the limit of detection in seeded whole
blood was determined. Thus, cells of different Candida
species were artificially inoculated in whole blood from
healthy volunteers in concentrations ranging from
2.5102 to 1.25 cells/ml and DNA was isolated from
a 3.6 ml sample. Cells in the exponential phase of
growth were used and their viability (assessed as
plasma membrane integrity) was confirmed by flow
cytometry in order to exclude from the presence of
dead Candida cells that could contribute to the release
of DNA, masking the sensitivity of the method (data
not shown). Using the proposed multiplex protocol, the
PCR products presented the characteristic mobility
pattern, correctly identifying the species seeded in
whole blood (Fig. 2D exemplifies the case of
C. albicans). Additionally, the sensitivity of the multi-
plex PCR was found to be 2.1590.25 cells per ml of
blood. On the other hand, in the particular case of
simulated polyfungal infections, both species could be
correctly identified to a minimum limit of approxi-
mately 20 cells/ml, although one of them was always
detected to the minimum limit achieved for individual
species (data not shown).
Discussion
The development of a simple approach to the identi-
fication of Candida species based on the combined use
of universal yeast primers and Candida species-specific
primers was undertaken. The universal primers were
first reported by Trost and colleagues, who further
developed a method based on the enzyme restriction of
PCR fragments in order to identify a set of fungal
pathogens [18]. While universal primers provide a
broad detection capability for yeast pathogens [18], in
the present work, the presence of species-specific
primers allow differentiation of Candida at the species
level in a single PCR reaction. The multiplex PCR
strategy herein described takes advantage of the high-
copy number of rRNA genes, the differences in the
length of ITS regions and the high variability of these
regions among Candida species. This strategy renders
the method with a test matrix able to identify eight of
the most clinically relevant yeast species, including the
newly emerging C. dubliniensis, as shown with the type
strain (Fig. 2A). Together, both the universal and
species-specific fragments result in characteristic band
patterns, enabling easy identification of the Candida
species in question. Similarly to other genotypic-based
techniques, this method allows for the identification of
species that have non-standard morphologic, cultural














































































































































































































































































































































































































































































































































































– 2007 ISHAM, Medical Mycology, 45, 619627
Multiplex PCR identification of Candida species 625
amplification of isolated DNA, the identification of
living/intact whole cells in the PCR mixture was also
found to be possible (Fig. 2B), thus bypassing the time-
consuming DNA isolation steps and reducing the time
required for identification. Another advantage of this
methodology resides in the rapid identification in the
same multiplex PCR reaction of the etiologic agents
involved in polyfungal infections (Fig. 2C). Such cases
involving more than one yeast have been reported to
occur with a frequency of approximately 5% among all
candidemias [27]. Furthermore, yeast species was not
hampered by the presence of bacteria frequently co-
infecting candidemia patients.
The identification of Candida species was also carried
out directly from clinical samples such as blood culture
bottles and urine samples. The isolation of Candida
DNA from aliquots of blood culture bottles required 2
h to lyse blood cells and recover DNA, 2 h for
multiplex PCR amplification of isolated DNA and 1
h to perform agarose gel electrophoresis, including the
time required to prepare the PCR mixture and agarose
gel. Therefore, species can be identified within as little
as 5 h, in contrast to phenotypic methods which can
take several days [28]. Furthermore, this methodology
is highly sensitive since the number of yeast cells
detectable in artificially inoculated whole blood reached
a minimum limit of 2.1590.25 cells/ml (Fig. 2D). This
capacity may enable the method to detect low candi-
demias occurring in the early stages of infection, given
that there are often less than 10 Candida cells circulat-
ing per ml of blood in these situations [29]. Moreover,
this multiplex strategy is adaptable to diverse standard
equipment currently in use in most clinical laboratories
and if not, likely to be easily implemented. The
technique is cost-effective since it only requires essen-
tially PCR components and DNA isolation reagents.
Furthermore, no DNA probes or expensive restriction
enzymes are needed. Finally, the possibility of detection
of candidemia cases directly from patients’ whole blood
is currently under investigation and efforts are being
carried out to validate the applicability of the method
in clinical settings.
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